It was originally developed for type 2 diabetes management (Ozempic) but showed such dramatic weight loss effects that the FDA approved a higher-dose formulation for chronic weight management (Wegovy)
GLP-1s have added benefits in that they also reduce the risk of heart diseases, such as heart failure and stroke, and improve blood pressure and cholesterol levels
This slow escalation allows your body to adapt to the appetite suppression and gastrointestinal changes caused by semaglutide, reducing the risk of severe nausea, vomiting, or other side effects that might force you to discontinue treatment early
Left ventricular end-diastolic dimension (LVEDD), left ventricular end-systolic dimension (LVESD), fractional shortening (FS), ejection fraction (EF), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), stroke volume (SV) and cardiac output (CO) were analyzed by using Visual Sonics software